Johnson & Johnson's ICOTYDE® Shows Promising Two-Year Results in Psoriasis Treatment #USA #Johnson_&_Johnson #Spring_House #Psoriasis #ICOTYDE
@newsen.bsky.social
@newsen.bsky.socialJohnson & Johnson's ICOTYDE® Shows Promising Two-Year Results in Psoriasis Treatment #USA #Johnson_&_Johnson #Spring_House #Psoriasis #ICOTYDE
@dailynorthern.comGovernment plans to end funding for psoriasis treatment trips #Croatia #healthcare #psoriasis
@dailynorthern.comGovernment removes funding for patients’ treatment abroad #healthcare #psoriasis #rheumatism
@psoriasisclub.orgIn this retrospective cohort of 228 Chinese patients with chronic plaque psoriasis, 52 weeks of Tremfya (guselkumab) treatment was associated with a modest but statistically significant reduction in serum uric acid.
@yuuiko7.bsky.social$JNJ two-year data from the ICONIC-TOTAL trial shows icotinib delivering strong clearance at psoriasis's hardest-to-treat sites.
- 60% complete scalp clearance at Week 112
- 89% complete genital clearance at Week 112
- Results hold through two full years of treatment
@psoriasisclub.orgEmerging evidence suggests a link between psoriasis (PSO), psoriatic arthritis (PSA), and periodontitis (PE)
@psoriasisclub.orgThis study looked at Generalised Pustular Psoriasis (GPP) and mortality risk in English patients.
@minzi2024.bsky.socialadded psoriasis to my illnesses collection 🙄 #psoriasis #chronicillness
@jrheumatol.bsky.socialRheumatology Around the World 🌎
Epidemiological Characteristics of Psoriatic Disease in Peru From 2016 to 2023
@achronicvoice.com"I struggle with very #DrySkin as well as #psoriasis, neither of which was an issue..before developing #fibromyalgia ..I’m trying to be more consistent abt looking after my #skin rather than only doing something when it becomes..irritated.": buff.ly/6UtmC3F
by sswarbo
#ChronicPain #dermatology
@robertlufkinmd.bsky.socialThis does not prove weight loss alone explains the skin benefit. My takeaway: metabolic health deserves a place in the treatment conversation, not a promise that one drug fixes everything.
#MetabolicHealth #Psoriasis #ClinicalTrials #HealthLongevitySecrets (4/5)
@jrheumatol.bsky.socialProceedings
The 2nd Brazilian GRAPPA International Meeting on Psoriasis and Psoriatic Arthritis – 2° Encontro Internacional do GRAPPA Sobre Psoríase e Artrite Psoriásica
📖 www.jrheum.org/cgi/content/...
@uspoficial.bsky.social @uwsom-wwami.bsky.social
@byalung.bsky.socialStephen Lashbrook says his severe psoriasis improved dramatically after adopting the lion diet. But nutrition specialists warn that eliminating nearly all food groups can create nutritional and digestive risks. #Psoriasis #CarnivoreDiet
@thejidinnovations.bsky.socialHematological inflammatory markers as predictors of atherosclerotic progression in patients with #psoriasis: A retrospective case–control study from the SH-YIMED database
Zhang et al
https://doi.org/10.1016/j.xjidi.2026.100535
#DermatologyJournal #dermatologist #dermresearch #dermscience
@dermimmuno.bsky.socialAccording to an evaluation of long-term data by April Armstrong (@domucla.bsky.social), #deucravacitinib demonstrated a consistent safety profile and durable clinical response through 5 years for patients with moderate to severe #psoriasis. #PsO #Dermatology
@dermatologyadvisor.bsky.socialRates of response to treatment for plaque #psoriasis was 70.1% with biologic therapies, 45.8% with methotrexate, and 54.7% with phototherapy.
@kill-bait.bsky.socialFlorida Man Reports Significant Health Improvements After Adopting Strict Carnivore Diet
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#diet #psoriasis #mentalhealth
👇👇👇
@eagleeyephx.comStress can do more than drain your energy—it can also trigger psoriasis flare-ups. Taking a few minutes each day to relax, breathe, walk, meditate, or do something you enjoy may help reduce stress and support healthier skin. Your mind and skin are connected. 💙 #Psoriasis
@newsen.bsky.socialAbbVie Receives New Approval for Pediatric Use of Skyrizi in Psoriasis Treatment #Japan #Tokyo #Psoriasis #AbbVie #Skyrizi
@pharmaphorum.bsky.socialThe #FDA has started a review of the #marketingapplication for #Takeda's #TYK2inhibitor zasocitinib in #psoriasis, setting up a decision in mid-March 2027.